Company page

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. (ticker: CLRB) is a public company based in the United States, specializing in the development of targeted therapies for cancer. With a market capitalization of approximately $19.3 million, Cellectar focuses on innovative treatments aimed at improving patient outcomes. The company is committed to advancing its proprietary drug delivery platform to enhance the effectiveness of cancer therapies.

CLRB:NASDAQUpdated August 28, 2026
Cellectar Biosciences, Inc. logo
Ticker
CLRB:NASDAQ
Asset type
Stock
Market cap
$23.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD